Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 04, 2017 01:07 ET | Source: Ogeda SA

Ogeda SA: Ogeda announces positive data from Phase IIa trial of fezolinetant (ESN364) in the treatment of menopausal hot flashes

Ogeda announces positive data from Phase IIa trial of fezolinetant (ESN364) in the treatment of menopausal hot flashes Primary end points met with significant reduction versus placebo seen...
December 20, 2016 01:43 ET | Source: Ogeda SA

Ogeda announces fezolinetant as INN and issuance of U.S. patent for ESN364

Ogeda announces fezolinetant as INN and issuance of U.S. patent for ESN364 Ogeda, a clinical-stage drug discovery company that invents and develops small molecule drug candidates targeting...